Breast cancer survivors can lose weight through modest lifestyle changes
the ONA take:
Female breast cancer survivors may be able to lose weight through modest lifestyle changes, according to a recent study presented at the American Society of Clinical Oncology (ASCO) 2015 meeting in Chicago.
Tim Byers, MD, MPH, of the University of Colorado Cancer Center and fellow researchers looked at 700 women at four sites around the U.S. for two years as part of a randomized control trial in which half of the participants underwent lifestyle interventions.
“The goal was to lose seven percent of their body weight and maintain it for two years,” said study collaborator Rebecca Sedjo, PhD. The women in the intervention group attended motivational meetings which focused on increasing physical activity and decreasing caloric intake.
Within the first 12 months, average weight loss among the participants in the intervention group was six percent of total body weight.
“This is a significant finding because it shows that women are able to lose weight after breast cancer treatment and this may lead to reduced risk of recurrence,” said Dr. Byers.
Female breast cancer survivors may be able to lose weight through modest lifestyle changes.
Sign Up for Free e-newsletters
- Real World Results May Not Mirror Clinical Study Outcomes in Multiple Myeloma
- Is Radioimmunotherapy a Path Forward for Melanoma?
- Handling Chemotherapy Premedications
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|